01:31 PM EST, 01/16/2025 (MT Newswires) -- Atara Biotherapeutics ( ATRA ) reported "compliance issues" on Thursday involving a third-party manufacturing facility for Ebvallo, a treatment for patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease.

Shares slumped 37% as intraday trading volume catapulted to over 1.8 million million versus a daily average of about 127,000.

Silexion Therapeutics ( SLXN ) shares slumped intraday after the company overnight disclosed a $5 million equity offering to fund pre-clinical studies.

Shares plunged 42% as intraday trading volume rose to roughly 6.58 million from the stock's daily average of about 4.63 million.

US Bancorp ( USB ) shares dropped after the company reported Thursday Q4 revenue that missed expectations.

Shares slid 5%, with intraday trading volume at nearly 11.6 million versus the stock's daily average of over 7.61 million.

Price: 8.29, Change: -4.87, Percent Change: -37.00